The potential benefit of trastuzumab-based therapy upon lapatinib progression in heavily preatreated patients with advanced HER2 positive breast cancer.
Anastasios L. Boutis
No relevant relationships to disclose
Sofia Chatzileontiadou
No relevant relationships to disclose
Nikolaos Diamantopoulos
No relevant relationships to disclose
Athanasios Pouptsis
No relevant relationships to disclose
Chariklia Fotiou
No relevant relationships to disclose